Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Total Assets (Quarterly) : 176.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 176.09M |
| March 31, 2026 | 191.92M |
| December 31, 2025 | 209.47M |
| September 30, 2025 | 144.64M |
| June 30, 2025 | 156.93M |
| March 31, 2025 | 168.56M |
| December 31, 2024 | 181.45M |
| September 30, 2024 | 94.09M |
| June 30, 2024 | 101.65M |
| March 31, 2024 | 68.13M |
| December 31, 2023 | 78.95M |
| September 30, 2023 | 88.47M |
| June 30, 2023 | 95.14M |
| March 31, 2023 | 106.40M |
| December 31, 2022 | 113.29M |
| September 30, 2022 | 148.59M |
| June 30, 2022 | 154.88M |
| March 31, 2022 | 161.26M |
| December 31, 2021 | 172.60M |
| September 30, 2021 | 180.70M |
| June 30, 2021 | 188.89M |
| March 31, 2021 | 192.41M |
| December 31, 2020 | 203.16M |
| September 30, 2020 | 198.91M |
| June 30, 2020 | 63.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 70.10M |
| December 31, 2019 | 1.223M |
| September 30, 2019 | 9.648M |
| June 30, 2019 | 11.60M |
| March 31, 2019 | 18.06M |
| December 31, 2018 | 23.52M |
| September 30, 2018 | 27.40M |
| June 30, 2018 | 27.85M |
| March 31, 2018 | 38.51M |
| December 31, 2017 | 43.98M |
| September 30, 2017 | 48.56M |
| June 30, 2017 | 33.63M |
| March 31, 2017 | 36.02M |
| December 31, 2016 | 43.52M |
| September 30, 2016 | 49.40M |
| June 30, 2016 | 55.66M |
| March 31, 2016 | 61.34M |
| December 31, 2015 | 67.54M |
| September 30, 2015 | 72.28M |
| June 30, 2015 | 76.58M |
| March 31, 2015 | 80.93M |
| December 31, 2014 | 84.80M |
| September 30, 2014 | 24.18M |
| June 30, 2014 | 27.14M |
| March 31, 2014 | 4.045M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0647M |
| Brainstorm Cell Therapeutics, Inc. | 0.788M |
| Summit Therapeutics, Inc. | 752.18M |
| Kezar Life Sciences, Inc. | 68.00M |
| Clene, Inc. | 23.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.78M |
| Shareholders Equity (Quarterly) | 161.31M |
| Debt to Equity Ratio | 0.017 |
| Current Ratio | 10.97 |
| Net Debt Paydown Yield | 0.13% |